A Study to Investigate the Appearance and Disappearance of ASP3652 in Blood and Spinal Fluid in Healthy Male Subjects

Clinical trial NCT02034734 · COMPLETED

Trial details

NCT number: NCT02034734
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics of ASP3652 Pharmacodynamics of ASP3652 Healthy Subjects

Start date: 2012-09-01
Primary completion: 2012-12-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.